Skip to content

Management of Acute Cardiogenic Shock at the New Brunswick Heart Centre

Management of Acute Cardiogenic Shock at the New Brunswick Heart Centre

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05414643
Acronym
Team-Shock
Enrollment
1416
Registered
2022-06-10
Start date
2021-01-14
Completion date
2021-10-13
Last updated
2022-06-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiogenic Shock

Keywords

mortality, outcomes, AMI, shock team, SCAI stage, intervention, IABP, ECMO

Brief summary

In Atlantic Canada, acute myocardial infarction occurs at a rate of 2.9 % of the population and is the most common cause of cardiogenic shock (CS). In many studies, acute myocardial infarction accounts for up to 80% of the patients with CS. While there are different methods of treating patients with CS, the rate of mortality has not significantly improved over the years and remains as high as 50%. Recent studies have shown that a multi-modal, team-based approach can help improve patient outcomes; however, such a standardized approach is yet to be implemented in the New Brunswick Heart Centre (NBHC). The study aims to understand the difference in outcomes between two groups of patients treated for CS: SHOCK TEAM versus non-SHOCK TEAM. This is a retrospective study of 168 patients using the data from NBHC registry and patient charts. The study duration is 1 year. The primary outcome is hospital survival. Secondary outcomes include time from diagnosis to invasive monitoring and intervention. All data will be analyzed statistically between the two groups. The end goal of the study is to establish standard guidelines to treat CS patients and improve patient survival.

Interventions

OTHERStandard care

No interventions were used, as this is an observational study.

Sponsors

New Brunswick Heart Centre
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

1\) Any patient admitted to the CCU with a diagnosis of CS (SCAI groups C, D or E) at any point during their CCU care.

Exclusion criteria

1\) CS patients having SCAI groups A, B (this group was used only for preliminary analysis, hence this is the

Design outcomes

Primary

MeasureTime frameDescription
Percentage mortalityFrom the date of hospital admission at Saint John Regional Hospital to the date of discharge, assessed upto 6 monthsAny in-hospital mortality (within Saint John Regional Hospital, another hospital after transfer)
Length of stay (LOS))From the date of hospital admission at Saint John Regional Hospital to the date of discharge, assessed upto 6 monthsLOS was considered only for patients who were discharged directly home from Saint John Regional Hospital
Discharge dispositionFrom the date of hospital admission at Saint John Regional Hospital to the date of discharge, assessed upto 6 monthsDischarge of patients home, transfer to another hospital or to another institution (special care home, extra-mural home)
Percentage of missed opportunitiesFrom the date of hospital admission at Saint John Regional Hospital to the date of discharge, assessed upto 6 monthsMissed opportunities was defined as patients who suffered significant delays or those who did not receive any intervention

Secondary

MeasureTime frameDescription
Time from diagnosis of shock to in-hospital processesFrom the date of hospital admission at Saint John Regional Hospital to the date of discharge, assessed upto 6 monthsTime gaps between the first diagnosis of a cardiogenic shock to in-hospital processes like invasive monitoring, cardiac catheterization or interventions (surgery, PCI, TAVI, IABP or ECMO).

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026